10 Year Financial Data of Medifast, Inc. (MED)

28.47 (1y: +55%)

Market Cap	389.42 M	P/E(ttm)	22.30
Enterprise Value	321.43 M	P/B	4.40

MED- NYSE (USA)
Medifast, Inc.

Currently 5/5

Business Predictability Rank: 5-Star
Back Testing Results:
Average gain of all 5-Star stocks: 12.1% per year.
% of Stocks that are in still loss if held for 10yrs: 3%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies

$28.47

1 Medium Warning Sign 3 Good Signs

Bookmark

Annual Rates (per share)	10 yrs*	5 yrs*	12 months*
Revenue Growth (%)	34.2	37	18.2
EBITDA Growth (%)	28.9	28.2	16.9
Free Cash Flow Growth (%)	0	0	1.9
Book Value Growth (%)	18.7	25.3	23.7

*12-month growth rate is calculated with the per share revenue (EBITDA, FCF, earnings) of the last 12 months over the per share revenue (EBITDA, FCF, earnings) over the previous 12 months. 5-year and 10-year growth rates are calculated with least-square regression based on the 5-year and 10-year numbers.

Trendline:

Export:

Print This Table Print

See this page for the explanation of the data and charts * All numbers are in millions except for per share data

Per Share Data	Annuals											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	TTM	Mar12	Jun12	Sep12	Dec12	Mar13

Revenue per Share ($)	2.32	2.20	3.14	5.49	6.14	7.36	11.24	17.67	21.00	25.96	26.30	6.43	6.76	6.59	6.05	6.90
EBITDA per Share	0.39	0.35	0.45	0.78	0.67	0.89	1.67	2.57	2.52	2.51	2.70	0.62	0.54	0.87	0.48	0.81
Free Cashflow per Share	-0.14	0.03	0.12	-0.16	--	-0.14	1.02	1.15	1.42	2.10	1.65	1.32	0.57	0.45	-0.25	0.88
Earnings per Share ($)	0.22	0.14	0.19	0.38	0.28	0.38	0.81	1.35	1.31	1.16	1.29	0.29	0.20	0.52	0.14	0.43
Book Value per Share	1.56	1.55	1.72	2.09	2.38	2.66	3.36	4.94	5.17	6.61	6.99	5.65	5.74	6.32	6.60	6.99
Month End Stock Price	14.10	3.52	5.24	12.57	4.85	5.52	30.58	28.88	13.72	26.39	22.92	17.46	19.68	26.15	26.39	22.92
Ratios	Annuals											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Latest Q.	Mar12	Jun12	Sep12	Dec12	Mar13

Return on Equity %	14.10	9.10	12.40	18.00	11.80	14.20	24.10	27.30	25.30	17.50	24.40	20.40	14.00	33.20	8.40	24.40
Return on Assets %	9.90	6.70	8.90	13.80	8.80	10.60	19.10	20.80	17.50	12.20	17.60	13.60	9.20	22.40	5.60	17.60
Return on Capital - Joel Greenblatt %	32.20	21.80	24.60	35.60	22.30	23.50	53.40	75.70	54.50	57.50	97.60	66.80	56.80	104	35.60	97.60
Debt to Equity	0.32	0.27	0.24	0.19	0.20	0.20	0.13	0.08	0.08	0.05	0.01	0.07	0.06	0.05	0.05	0.01

Gross Margin %	73.10	75.30	74.70	75.40	74.40	76.00	75.70	74.70	75.30	75.10	75.40	75.10	75.00	75.10	75.40	75.40
Operating Margin %	14.20	11.00	10.20	10.90	6.80	7.80	11.70	12.30	9.20	6.50	8.90	6.90	4.90	9.80	4.30	8.90
Net Margin %	9.50	6.40	6.80	6.90	4.60	5.20	7.20	7.60	6.20	4.50	6.20	4.50	3.00	7.90	2.20	6.20

Days Sales Outstanding	9.20	14.20	9.00	3.10	2.90	2.20	1.60	0.90	1.80	2.20	2.30	2.20	2.30	2.70	2.30	2.30
Days Inventory	160	230	197	165	156	200	102	110	98.90	85.60	70.90	63.00	63.20	73.50	92.60	70.90
Inventory Turnover	2.30	1.60	1.90	2.20	2.30	1.80	3.60	3.30	3.70	4.30	1.30	1.40	1.40	1.20	1.00	1.30

Debt to Revenue	0.21	0.19	0.13	0.07	0.08	0.07	0.04	0.02	0.02	0.01	0.01	0.06	0.05	0.05	0.05	0.01
COGS to Revenue	0.27	0.25	0.25	0.25	0.26	0.24	0.24	0.25	0.25	0.25	0.25	0.25	0.25	0.25	0.25	0.25
Inventory to Revenue	0.12	0.16	0.14	0.11	0.11	0.13	0.07	0.08	0.07	0.06	0.19	0.17	0.17	0.20	0.25	0.19
Interest Exp. to Revenue %	-0.59	-0.33	-0.40	-0.26	-0.34	-0.21	0.01	0.11	0.11	0.08	0.05	--	--	--	0.09	0.05

Asset Turnover	1.05	1.05	1.31	2.01	1.92	2.07	2.64	2.74	2.82	2.74	0.71	0.76	0.77	0.71	0.64	0.71
Buyback Ratio	-279	-0.40	-2.40	-15.60	-5.60	-0.60	-1.80	-0.20	--	--	--	--	--	--	--	--
Income Statement	Annuals (USD $) View: $ %											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	TTM	Mar12	Jun12	Sep12	Dec12	Mar13

Revenue	25.38	27.34	40.13	74.09	83.78	105	166	258	298	357	364	88.92	93.57	90.97	83.24	96.04
Cost of Goods Sold	6.83	6.75	10.16	18.24	21.46	25.33	40.29	65.08	73.69	88.67	90.14	22.17	23.43	22.63	20.44	23.63
Gross Profit	18.55	20.59	29.97	55.85	62.32	80.11	125	192	224	268	274	66.76	70.14	68.34	62.80	72.41

Selling, General, &Admin. Expense	14.96	17.59	25.89	48.27	56.60	71.91	106	161	197	245	248	60.62	65.54	59.41	59.21	63.83
Earnings Before DDA	4.28	4.31	5.82	10.51	9.19	12.77	24.63	37.50	35.73	34.47	37.16	8.52	7.41	11.96	6.59	11.21

Depreciation, Depletion and Amortization	0.68	1.31	1.74	2.40	3.47	4.57	5.27	5.86	8.34	11.21	11.45	2.38	2.81	3.03	2.99	2.63

Operating Income	3.60	3.00	4.07	8.11	5.72	8.20	19.37	31.64	27.38	23.26	25.70	6.14	4.60	8.93	3.60	8.58
Interest Income/Expense	-0.15	-0.09	-0.16	-0.19	-0.28	-0.22	0.01	0.27	0.32	0.30	0.13	--	--	--	0.07	0.05
Net Income	2.41	1.75	2.73	5.08	3.84	5.44	11.96	19.61	18.54	15.88	17.82	3.99	2.81	7.21	1.87	5.93

Preferred dividends	0.06	0.02	0.29	--	--	--	--	--	--	--	--	--	--	--	--	--
Earnings per Share ($)	0.22	0.14	0.19	0.38	0.28	0.38	0.81	1.35	1.31	1.16	1.29	0.29	0.20	0.52	0.14	0.43
Total Shares Outstanding	10.95	12.41	12.78	13.48	13.64	14.33	14.74	14.57	14.20	13.74	13.91	13.83	13.83	13.80	13.76	13.91
Balance Sheet	Annuals (USD $) View: $ %											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Latest Q.	Mar12	Jun12	Sep12	Dec12	Mar13

Cash and cash equivalents	6.51	3.24	4.18	2.63	3.63	2.94	16.30	34.44	33.80	59.99	68.90	51.99	56.56	62.92	59.99	68.90
Accounts Receivable	0.64	1.06	0.99	0.62	0.67	0.63	0.72	0.62	1.48	2.15	2.45	2.18	2.40	2.73	2.15	2.45
Inventory	2.99	4.25	5.48	8.26	9.18	13.86	11.23	19.53	19.97	20.80	18.42	15.35	16.27	18.28	20.80	18.42
Other Current Assets	1.85	1.42	3.80	3.36	3.64	3.80	6.47	6.08	8.74	5.63	5.12	6.26	4.28	3.67	5.63	5.12
Total Current Assets	11.99	9.97	14.44	14.86	17.13	21.22	34.73	60.67	63.99	88.58	94.89	75.77	79.50	87.59	88.58	94.89

Property, Plant and Equipment	7.45	8.70	9.54	14.02	17.03	21.71	23.24	30.59	38.85	40.11	40.13	39.19	39.62	38.95	40.11	40.13
Intangible Assets	4.42	7.14	6.51	6.27	7.36	5.55	4.10	1.07	1.00	0.43	0.30	0.90	0.74	0.59	0.43	0.30
Other Long Term Assets	0.37	0.16	0.06	1.77	2.21	2.56	0.68	1.73	1.82	1.14	0.49	1.41	1.10	1.17	1.14	0.49
Total Assets	24.23	25.97	30.55	36.93	43.72	51.04	62.76	94.06	106	130	136	117	121	128	130	136

Accounts Payable	1.71	0.94	2.26	2.91	4.28	3.83	4.99	15.02	18.83	28.22	30.96	26.16	30.09	29.43	28.22	30.96
Current Portion of Long-Term Debt	0.82	0.83	1.19	1.80	1.86	3.42	0.80	0.94	1.43	0.53	0.28	1.29	0.55	0.56	0.53	0.28
Other Current Liabilities	0.06	0.74	0.99	0.54	0.59	1.30	0.40	--	0.00	--	--	--	--	--	--	--
Total Current Liabilities	2.59	2.51	4.45	5.25	6.73	8.55	6.18	15.96	20.26	28.75	31.24	27.45	30.64	29.99	28.75	31.24

Long-Term Debt	4.56	4.26	3.98	3.51	4.57	4.31	5.44	4.86	4.25	3.81	0.64	4.12	4.07	3.93	3.81	0.64
Other Long-Term Liabilities	--	-0.00	0.10	-0.00	--	0.00	1.55	1.28	7.76	6.91	6.62	7.59	6.86	7.15	6.91	6.62
Total Liabilities	7.16	6.76	8.52	8.76	11.30	12.86	13.18	22.10	32.26	39.47	38.50	39.16	41.56	41.07	39.47	38.50

Common Stock	0.01	0.01	0.01	0.01	0.01	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02
Preferred Stock	0.67	0.50	--	--	--	--	--	--	--	--	--	--	--	--	--	--
Retained Earnings	-3.02	-1.29	1.15	6.23	9.82	15.25	24.26	42.12	60.66	76.53	82.47	64.65	67.46	74.67	76.53	82.47
Additional Paid-In Capital	20.12	20.56	21.76	26.63	26.95	30.79	28.46	32.94	36.08	40.19	40.74	36.65	38.00	38.46	40.19	40.74
Treasury Stock	-0.68	-0.54	-1.08	-1.69	-1.97	-1.96	-3.32	-3.36	-23.74	-26.51	-26.51	-23.74	-26.51	-26.51	-26.51	-26.51
Total Equity	17.08	19.21	22.02	28.17	32.42	38.17	49.58	71.96	73.40	90.79	97.31	78.10	79.40	87.23	90.79	97.31
Cashflow Statement	Annuals (USD $) View: $ %											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	TTM	Mar12	Jun12	Sep12	Dec12	Mar13

Net Income	2.41	1.75	2.73	5.08	3.84	5.44	11.96	19.61	18.54	15.88	17.82	3.99	2.81	7.21	1.87	5.93
Depreciation, Depletion and Amortization	0.68	1.31	1.74	2.40	3.47	4.57	5.27	5.86	8.34	11.21	11.45	2.38	2.81	3.03	2.99	2.63
Cash Flow from Others	-1.34	-0.73	-1.26	-1.63	0.65	-4.51	3.08	3.30	7.99	13.18	5.06	14.34	5.12	-1.96	-4.31	6.22
Cash Flow from Operations	1.75	2.33	3.21	5.85	7.95	5.50	20.31	28.77	34.87	40.26	34.34	20.71	10.74	8.28	0.54	14.78

Investment for Property, Plant & Equipement	-3.33	-1.99	-1.67	-7.98	-7.97	-7.44	-5.35	-12.06	-14.66	-11.38	-11.43	-2.49	-2.86	-2.09	-3.95	-2.54
Cash Flow from Investing	-9.03	-3.94	-2.03	-6.75	-7.97	-7.31	-7.93	-23.54	-16.87	-11.66	-10.97	-2.77	-2.37	-1.96	-4.57	-2.07

Net Issuance of Stock	6.57	0.01	-0.39	0.38	-0.09	0.03	0.11	-0.00	-20.39	-2.76	-2.76	--	-2.76	--	--	--
Net Issuance of Debt	2.29	-0.30	0.09	0.14	1.12	1.30	-1.32	-0.44	-1.14	-1.43	-4.57	-0.27	-0.89	-0.13	-0.13	-3.42
Cash Flow for Dividends	-0.05	-0.01	-0.01	--	--	--	--	--	--	--	--	--	--	--	--	--
Other Financing	0.15	-0.00	-0.00	-0.01	0.10	0.13	-0.30	1.77	0.63	1.27	1.26	0.00	0.47	0.11	0.69	--
Cash Flow from Financing	8.96	-0.30	-0.31	0.50	1.13	1.46	-1.51	1.33	-20.90	-2.93	-6.07	-0.27	-3.19	-0.03	0.56	-3.42

Net Change in Cash	1.69	-1.91	0.87	-0.40	1.11	-0.35	10.87	6.56	-2.90	25.68	17.30	17.67	5.19	6.29	-3.47	9.29

Free Cash Flow	-1.59	0.34	1.54	-2.14	-0.01	-1.95	14.96	16.71	20.21	28.88	22.91	18.22	7.89	6.19	-3.41	12.25
Valuation Ratios (Daily)	Annuals											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Latest Q.	Mar12	Jun12	Sep12	Dec12	Mar13

PE Ratio(ttm)
Price to Tangible Book
Price-to-Free-Cash-Flow ratio
PS Ratio
EV-to-Revenue
EV-to-EBITDA
EV-to-EBIT
Earnings Yield (Joel Greenblatt)
Forward Rate of Return
Shiller PE Ratio
Valuation and Quality	Annuals											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Latest Q.	Mar12	Jun12	Sep12	Dec12	Mar13

Market Cap
Enterprise Value
Month End Stock Price
Net Cash (per share)
Net Current Asset Value (per share)
DCF (per share)
Median PS (per share)
Peter Lynch Fair Value (per share)
Graham Number (per share)
Altman Z-Score
Piotroski F-Score
Beneish M-Score

Switch to Another Stock:

MED Quarterly/Annuals Reports

MED: 10-Q - MEDIFAST INC (0000910329) (Filer): (10-Q) - 2012-11-09
MED: 10-Q - MEDIFAST INC (0000910329) (Filer): (10-Q) - 2012-08-09
MED: 10-Q - MEDIFAST INC (0000910329) (Filer): (10-Q) - 2012-05-10
MED: 10-K - MEDIFAST INC (0000910329) (Filer): (10-K) - 2012-03-15
MED: 10-Q - MEDIFAST INC (0000910329) (Filer): (10-Q) - 2011-08-09

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names

Home About Jobs Advertise Site Map Term of Use Privacy Policy RSS Email Alerts Affiliate Program FAQ Contact Us
Disclaimers: GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.

FocusBar

Home

Premium Membership

Value Screens

Model Portfolios

Guru Stocks

Market Valuation

By Country

Articles

Submit Articles

MED Quarterly/Annuals Reports